The role of innate immune signals in antitumor immunity

被引:20
作者
Jinushi, Masahisa [1 ]
机构
[1] Hokkaido Univ, Inst Genet Med, Res Ctr Infect Associated Canc, Sapporo, Hokkaido, Japan
关键词
toll-like receptor; RIG-I like helicase; NOD-like receptors; antitumor immunity; immunotheropy; PATTERN-RECOGNITION RECEPTORS; PLASMACYTOID DENDRITIC CELLS; REGULATORY T-CELLS; PHASE-II TRIAL; TOLL-LIKE; HUMAN-MELANOMA; RIG-I; CYTOPLASMIC DNA; CROHNS-DISEASE; CANCER-CELLS;
D O I
10.4161/onci.1.2.18495
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Innate immunity serves as a first line of defense against infectious agents, and germ-line-encoded pattern recognition receptors detect stressed and infected cells and elicit potent effector activities that accomplish efficient microbe containment. Recent evidence demonstrates that these pattern-sensing systems are also applicable to the recognition of tumor-derived stress-related factors. In particular, toll-like receptors and cytosolic sensors for DNA and RNA recognition utilize endogenous host elements containing microbial components, danger-associated molecules, and/or nucleic acids to stimulate innate signaling pathways and generate protective immune responses against nascent tumors in animal models and humans. In this review, we describe recent advances and perspectives about antitumor mechanisms and clinical application of innate immune signals and pathways.
引用
收藏
页码:189 / 194
页数:6
相关论文
共 57 条
  • [21] Immunity, Inflammation, and Cancer
    Grivennikov, Sergei I.
    Greten, Florian R.
    Karin, Michael
    [J]. CELL, 2010, 140 (06) : 883 - 899
  • [22] Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway
    Hemmi, H
    Kaisho, T
    Takeuchi, O
    Sato, S
    Sanjo, H
    Hoshino, K
    Horiuchi, T
    Tomizawa, H
    Takeda, K
    Akira, S
    [J]. NATURE IMMUNOLOGY, 2002, 3 (02) : 196 - 200
  • [23] Sequence-specific potent induction of IFN-α by short interfering RNA in plasmacytoid dendritic cells through TLR7
    Hornung, V
    Guenthner-Biller, M
    Bourquin, C
    Ablasser, A
    Schlee, M
    Uematsu, S
    Noronha, A
    Manoharan, M
    Akira, S
    de Fougerolles, A
    Endres, S
    Hartmann, G
    [J]. NATURE MEDICINE, 2005, 11 (03) : 263 - 270
  • [24] AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC
    Hornung, Veit
    Ablasser, Andrea
    Charrel-Dennis, Marie
    Bauernfeind, Franz
    Horvath, Gabor
    Caffrey, Daniel. R.
    Latz, Eicke
    Fitzgerald, Katherine A.
    [J]. NATURE, 2009, 458 (7237) : 514 - U6
  • [25] Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
    Hugot, JP
    Chamaillard, M
    Zouali, H
    Lesage, S
    Cézard, JP
    Belaiche, J
    Almer, S
    Tysk, C
    O'Morain, CA
    Gassull, M
    Binder, V
    Finkel, Y
    Cortot, A
    Modigliani, R
    Laurent-Puig, P
    Gower-Rousseau, C
    Macry, J
    Colombel, JF
    Sahbatou, M
    Thomas, G
    [J]. NATURE, 2001, 411 (6837) : 599 - 603
  • [26] Regulation of Adaptive Immunity by the Innate Immune System
    Iwasaki, Akiko
    Medzhitov, Ruslan
    [J]. SCIENCE, 2010, 327 (5963) : 291 - 295
  • [27] The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
    Kawai, Taro
    Akira, Shizuo
    [J]. NATURE IMMUNOLOGY, 2010, 11 (05) : 373 - 384
  • [28] Development of TLR9 agonists for cancer therapy
    Krieg, Arthur M.
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2007, 117 (05) : 1184 - 1194
  • [29] Targeted Activation of RNA Helicase Retinoic Acid-Inducible Gene-I Induces Proimmunogenic Apoptosis of Human Ovarian Cancer Cells
    Kuebler, Kirsten
    Gehrke, Nadine
    Riemann, Soheila
    Boehnert, Volker
    Zillinger, Thomas
    Hartmann, Evelyn
    Poelcher, Martin
    Rudlowski, Christian
    Kuhn, Walther
    Hartmann, Gunther
    Barchet, Winfried
    [J]. CANCER RESEARCH, 2010, 70 (13) : 5293 - 5304
  • [30] Randomized phase II trial of a toll-like receptor 9 agonist oligodeoxynucleotide, PF-3512676, in combination with first-line taxane plus platinum chemotherapy for advanced-stage non-small-cell lung cancer
    Manegold, Christian
    Gravenor, Donald
    Woytowitz, Donald
    Mezger, Joerg
    Hirsh, Vera
    Albert, Gary
    Al-Adhami, Mohammed
    Readett, David
    Krieg, Arthur M.
    Leichman, Cynthia Gail
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (24) : 3979 - 3986